“…In addition, at the whole-brain level, individuals with higher anxiety showed lower activation of the vlPFC to the safety compound than to the novel compound during early trials of the task (although this difference was not observed during later trials of the task). Given the involvement of the vlPFC in processes that include cognitive control, implicit emotion regulation, and affect labeling ( 43 , 44 , 45 , 46 , 47 ), this difference may be consistent with weaker regulation in the affective domain that has been shown in previous work on anxiety ( 48 , 49 , 50 , 51 , 52 ). We did not observe differences in recruitment of the vlPFC later in the task, which could suggest either that this region was no longer recruited across participants or that there was no longer a relationship to anxiety during the later trials.…”